Zacks Earnings Trends Highlights: Johnson & Johnson, Chevron and DuPont - Press Releases

Loading...
Loading...

For Immediate Release

Chicago, IL – August 31, 2010 - Zacks Research Equity Strategist, Dirk Van Dijk says that S&P 500 earnings are continuing to show red ink. He tracks companies on the Zacks.com web site, naming names, while forecasting trends for the months ahead.

Earnings to Recover by 2011

Earnings will have fully recovered by mid-2011, and that full-year 2011 earnings will be 8.6% above full-year 2007 earnings (before the Great Recession started). That is years before we are likely to see a full recovery in the job market. Collectively the 500 firms in the S&P 500 earned $548.8 billion in “2009,” and that is going to grow to $778.5 billion this year and $895.1 billion in 2011. Translated into “EPS” for the index, earnings are expected to rise from $57.85 in 2009 to $81.81 in 2010 and $94.34 in 2011.

In other words, then, the S&P 500 is selling for 18.4 x 2009 earnings, but just 12.8x 2010 and 11.1x 2011 earnings. By historical standards that is quite cheap. Normally, when interest rates and inflation are low, P/E ratios are higher than average. Well we currently have some of the lowest rates of inflation in decades and interest rates are at near record lows. It only costs the government 2.48% to borrow for 10 years. (These numbers are based on Thursday 8/26; stocks moved sharply higher on 8/27, as did t-note yields). It is not hard to find good solid blue chip companies that are providing dividend yields of more than that, and not just a bunch of electric utilities either.

One thing is certain: the coupon on a 10 year t-note will not increase over the next 10 years. The odds of the likes of Johnson & Johnson (JNJ) 3.70%, Chevron (CVX) 3.90%, or DuPont (DD) 4.10%, increasing their dividend in the next 10 years is pretty high. Currently 159 S&P 500 stocks yield over 2.48%, and 107 of those have payout ratios of less than 60%.

Earnings that are not paid out in dividends are reinvested for future growth, or are used to buy back stock, which also lifts earnings per share. Based on this year’s earnings, the earnings yield is 7.81% and based on next year it is 9.01%. Want stock picks from Zacks Equity Research that are based on earnings estimates? Subscribe to the free "Profit from the Pros" newsletter: http://at.zacks.com/?id=7161.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5618.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms. It monitors more than 200,000 earnings estimates, looking for changes.

Then, when changes are discovered, they’re applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.

The best way to unlock profitable Zacks' stock recommendations and market insights is through the free daily email newsletter: "Profit from the Pros." It provides a steady flow of profitable ideas GUARANTEED to be worth your time. Register for your free subscription at http://at.zacks.com/?id=5616.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Loading...
Loading...

Contact: Dirk Van Dijk, CFA
Company: Zacks.com
Phone: 312-265-9211
Email: pr@zacks.com
Visit: www.zacks.com

 



CHEVRON CORP (CVX
): Free Stock Analysis Report


DU PONT (EI) DE (DD
): Free Stock Analysis Report


JOHNSON & JOHNS (JNJ
): Free Stock Analysis Report


Zacks Investment Research
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Diversified ChemicalsEnergyHealth CareIntegrated Oil & GasMaterialsPharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...